Cohort Study on Plant-based Diets (COPLANT Study)
COPLANT
1 other identifier
observational
6,000
2 countries
8
Brief Summary
The Cohort on Plant-based Diets (COPLANT) study is a multi-centre cohort study that starts baseline recruitment from 2024 to 2027 with approximately 6,000 participants in Germany and Austria. The COPLANT study focuses on vegan (no animal products), vegetarian (no meat and fish, but dairy products and eggs), pescetarian (no meat, but fish) and omnivorous (mixed diet including all possible animal products) diets. The aim of the COPLANT study is to gain new insights on health benefits and risks as well as social, ecological and economic effects of different plant-based diets in comparison to a mixed diet. In addition to a detailed dietary survey using an app adapted to the needs of this study, the baseline examination includes measurements of body composition, bone health, cardiovascular risk factors, diabetes risk, contaminants and lifestyle. For the basic laboratory program, fasting blood, 24-hour urine collection and a stool sample are taken from all study participants. Furthermore, specific aspects of dietary behavior, physical activity and other lifestyle factors are collected via questionnaires. Follow-up studies are planned at intervals of 5, 10 and 20 years after the baseline visit.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2024
Longer than P75 for all trials
8 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 1, 2024
CompletedFirst Posted
Study publicly available on registry
March 21, 2024
CompletedStudy Start
First participant enrolled
April 9, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 31, 2047
February 14, 2025
February 1, 2025
3 years
March 1, 2024
February 13, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of diabetes type 2
Incidence of diabetes type 2
5, 10, 20 years
Secondary Outcomes (42)
Incidence of cardiovascular diseases
10, 20 years
Incidence of cancer
10, 20 years
Vitamin B12
Baseline
Holo-transcobalamine
Baseline
Homocysteine
Baseline
- +37 more secondary outcomes
Other Outcomes (5)
Heavy metals
Baseline
Halogenated, polycyclic aromatic hydrocarbons (dioxins)
Baseline
Mycotoxins
Baseline
- +2 more other outcomes
Study Arms (4)
vegans
vegan diet: no products of animal origin
vegetarians
vegetarian diet: no meat and fish, but dairy products and eggs
pescetarians
pescetarian diet: no meat, but fish
mixed diet
mixed diet: plant-based foods and animal-based foods
Eligibility Criteria
Vegans - no consumption of animal products (less than one exception per month) Vegetarians * no consumption of meat and fish (less than one exception per month) * consumption of eggs and/or dairy products (at least once a month) Pescetarians * no consumption of meat (less than one exception per month) * consumption of fish (at least once a month) * consumption of eggs or dairy products possible Omnivores/ mixed diet - group of non-exposed persons or control group \- consumption of meat or sausage (at least once a month).
You may qualify if:
- age between 18 and 69 years at recruitment (age-stratified recruitment in four age groups (18 to 29, 30 to 39, 40 to 49 and 50 to 69 years) which should be equally distributed across the four diets)
- following their current diet for at least one year
- health insured
- are willing to have blood taken (adults)
- are willing and able to complete questionnaires
- only at Berlin, Jena, Giessen and Karlsruhe sites: pregnant and breastfeeding women were recruited (shortened examination programm)
- only at the Regensburg, Heidelberg, Bonn and Vienna sites: are neither pregnant nor breastfeeding at the time of recruitment
- only at Berlin and Karlsruhe sites: children of adult participants (shortened examination programm without collection of blood, urine, and stool)
- are able to give informed consent to participate in the study
- have given their consent to participate in the COPLANT study
You may not qualify if:
- who can no longer be contacted
- who withdraw their consent to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- German Federal Institute for Risk Assessmentlead
- Max Rubner-Institutcollaborator
- University of Bonncollaborator
- Research Institute for Plant-Based Nutritioncollaborator
- University of Jenacollaborator
- University of Regensburgcollaborator
- Heidelberg Universitycollaborator
- University of Viennacollaborator
Study Sites (8)
University Vienna
Vienna, 1090, Austria
Max Rubner-Institut
Karlsruhe, Baden-Wurttemberg, 76131, Germany
Friedrich-Schiller University
Jena, Thuringia, 07743, Germany
The German Federal Institut for Risk Assessment
Berlin, 10589, Germany
University Bonn
Bonn, Germany
Research Institute for Plant-Based Nutrition, Gießen
Giessen, 35444, Germany
University Heidelberg
Heidelberg, 69120, Germany
University Regensburg
Regensburg, 93053, Germany
Related Links
Biospecimen
fasting blood samples, 24h urine, stool samples, saliva, breast milk
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ute Nöthlings, Prof
University Bonn
- PRINCIPAL INVESTIGATOR
Christine Dawczynski, PhD
University Jena
- PRINCIPAL INVESTIGATOR
Markus Keller, PhD
Research Institute for Plant-based Nutrition (IFPE)
- PRINCIPAL INVESTIGATOR
Michael Leitzmann, Prof
University Regensburg
- PRINCIPAL INVESTIGATOR
Ina Danquah, Prof
University Heidelberg
- PRINCIPAL INVESTIGATOR
Maria Wakolbinger, Prof
University Vienna
- PRINCIPAL INVESTIGATOR
Tilman Kühn, Prof
University Vienna
- PRINCIPAL INVESTIGATOR
Beate Fischer, PhD
University Regensburg
- PRINCIPAL INVESTIGATOR
Benedikt Merz, PhD
Max Rubner-Institut
- PRINCIPAL INVESTIGATOR
Cornelia Weikert, Prof
Federal Institut for Risk Assessment
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 1, 2024
First Posted
March 21, 2024
Study Start
April 9, 2024
Primary Completion (Estimated)
March 31, 2027
Study Completion (Estimated)
March 31, 2047
Last Updated
February 14, 2025
Record last verified: 2025-02